Seven new NHS Test Beds are being launched to tackle some of the biggest opportunities and challenges in health and care by testing combinations of innovations in real world clinical settings.
The new Test Beds are being provided with more than £7 million of Government funding, alongside match funding from industry partners. The products will be spread through the AHSN Network’s Innovation Exchanges, which match solutions to the needs of their local health and care systems.
AHSN Network Chair Professor Mike Hannay said: “This is a fantastic boost to the pace of innovating in the NHS. Our 15 AHSNs are ready to help spread the newly identified ‘rapid uptake’ AAC products and we will continue to support the exciting programme of Test Beds, providing advice on the development and delivery of innovations, and helping to spread those that prove beneficial across the health system.”
NHS Test Beds
This second wave of NHS Test Beds involves more than 30 collaborators from across the country include:
- Care City in London, which is bringing together market-ready diagnostics, smartphone applications and management tools to support patients with long-term conditionsl
- Nottingham University Hospitals NHS Trust, which is using artificial intelligence and machine learning to improve breast cancer screening
- Chelsea and Westminster NHS Foundation Trust, who will be providing patients with access to their digital health records with the aim of reducing missed appointments and duplication of clinical activity
- Royal Stoke University Hospital, who will be using new market-ready digital technologies to coordinate community-based clinical interventions for patients with heart failure, to reduce hospital re-admissions.
- Greater Manchester Strategic Clinical Networks, who will be testing a one-stop digital platform (MyDiabetesMyWay) designed to help people self-manage their condition more effectively
- South West London Health and Care Partnership, who will be using a combination of new technologies to empower patients to take control of managing their condition
- North East Hampshire and Farnham Clinical Commissioning Group (CCG), who will be providing using digital solutions embedded within existing diabetes pathways in primary care to provide structured, ongoing self-management support for lifestyle change.
